{
  "url": "https://www.nasdaq.com/article/health-care-sector-update-for-09112019-ttoo-lxrx-sny-tlry-jnj-pfe-mrk-abt-amgn-cm1210269",
  "title": "Health Care Sector Update for 09/11/2019: TTOO, LXRX, SNY, TLRY, JNJ, PFE, MRK, ABT, AMGN - Nasdaq.com",
  "text": [
    "Top Health Care Stocks:",
    "JNJ: Flat",
    "PFE: +0.13%",
    "ABT: Flat",
    "MRK: +0.42%",
    "AMGN: Flat",
    "Health care giants were mixed pre-bell Wednesday.",
    "Early movers include:",
    "(+) T2 Biosystems ( TTOO  ), which was surging by more than 34% after saying it has restructured its Term Loan Agreement with CRG Servicing, extending its interest-only payment period to March 2022 from March 2021 and reducing the minimum revenue targets for 2020 to 2022 to levels that are below its current financial forecast.",
    "(+) Lexicon Pharmaceuticals ( LXRX  ) was surging more than 30% after announcing that it has terminated its alliance with Sanofi ( SNY  ) for the development and commercialization of diabetes drug Zynquista. Lexicon regains all rights to Zynquista and will be paid $260 million by Sanofi, of which $208 million is payable upfront and $52 million payable within 12 months.",
    "(-) Tilray ( TLRY  ) was down more than 2% amid plans to issue up to $400 million shares of class 2 common stock in at-the-market sales.",
    "\nThe views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.\n",
    "\nCopyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.\n"
  ],
  "published_datetime": "2019-09-11 09:10:32"
}